The Gluten Question: Why Some People Feel Better Without It

For many years, discussions about gluten and health were framed in black and white: either you had Celiac Disease or gluten was harmless. Yet a growing body of research suggests a more complex middle ground. A condition now referred to as non-celiac gluten sensitivity (NCGS) appears to affect a subset of people who experience symptoms triggered by gluten despite not having celiac disease or a wheat allergy. Although still an evolving area of research, scientists are beginning to uncover biological mechanisms that may explain why removing gluten improves symptoms for some individuals.

Beyond Celiac Disease

Celiac disease is an autoimmune disorder in which gluten—proteins found in wheat, barley, and rye—triggers an immune reaction that damages the lining of the small intestine. In contrast, people with non-celiac gluten sensitivity do not show the intestinal damage or autoimmune antibodies that define celiac disease. Yet many report digestive symptoms such as bloating, abdominal pain, and diarrhoea, alongside systemic complaints including fatigue, headaches, joint pain, or “brain fog.”

Estimates vary, but research suggests that NCGS may affect between 1–6% of the population, though precise prevalence remains difficult to determine because there is no definitive diagnostic test.

The Role of Zonulin and Intestinal Permeability

One of the most intriguing biological explanations involves intestinal permeability, often referred to informally as “leaky gut.” The key regulator in this process is a protein called zonulin, which controls how tightly cells in the intestinal lining are joined together.

Zonulin regulates the opening and closing of structures known as tight junctions between intestinal cells. When zonulin levels increase, these junctions loosen slightly, allowing larger molecules—including fragments of food proteins—to pass through the intestinal barrier.

Research led by Alessio Fasano at Harvard Medical School demonstrated that gliadin, a component of gluten, can trigger the release of zonulin in certain individuals. This response temporarily increases intestinal permeability.

A landmark study published in Annals of the New York Academy of Sciences (Fasano, 2012) described zonulin as the first physiologic modulator of intercellular tight junctions identified in humans. Subsequent research has suggested that elevated zonulin levels may occur not only in celiac disease but also in individuals with gluten sensitivity.

When intestinal permeability increases, immune cells beneath the gut lining may encounter substances they would not normally see. This interaction can trigger inflammatory signalling and contribute to symptoms in susceptible individuals.

Evidence from Clinical Studies

While NCGS remains controversial in some scientific circles, several controlled trials have demonstrated measurable effects of gluten exposure.

A double-blind placebo-controlled trial published in The American Journal of Gastroenterology (Biesiekierski et al., 2011) found that participants without celiac disease experienced significantly worse gastrointestinal symptoms when consuming gluten compared with placebo.

Further research has shown that people with suspected NCGS may display markers of innate immune activation, even though they lack the autoimmune antibodies seen in celiac disease. A study in Gut (Sapone et al., 2011) observed that individuals with gluten sensitivity showed distinct immune responses and intestinal barrier changes compared with both healthy controls and those with celiac disease.

More recently, interest has expanded to include the role of wheat components beyond gluten, such as amylase-trypsin inhibitors (ATIs) and certain fermentable carbohydrates known as FODMAPs. These compounds may contribute to symptoms in some individuals, complicating efforts to isolate gluten as the sole trigger.

Why Some People Feel Better Gluten-Free

Given the complexity of wheat and its components, the benefits some individuals experience from removing gluten may arise from several mechanisms:

1. Reduced intestinal permeability in sensitive individuals: If gluten triggers increased zonulin release, reducing gluten exposure could stabilise tight junctions and limit inflammatory signalling.

2. Lower immune activation: Some individuals appear to mount an innate immune response to wheat proteins, leading to symptoms even in the absence of autoimmune disease.

3. Changes in gut fermentation: Many gluten-containing foods are also high in fermentable carbohydrates. Removing them may reduce bloating and digestive discomfort in people sensitive to these compounds.

4. Dietary shifts toward whole foods: Adopting a gluten-free diet often leads to increased attention to food quality, potentially increasing intake of naturally gluten-free foods such as vegetables, legumes, and whole grains like quinoa or buckwheat.

Importantly, gluten itself is not inherently harmful for the majority of people. Whole grains containing gluten provide fibre, B vitamins, and minerals that contribute to overall health.

However, the emerging science around non-celiac gluten sensitivity suggests that for a subset of individuals, gluten or other wheat components may contribute to real physiological symptoms. In these cases, a carefully structured gluten-free diet—ideally guided by a nutritional professional—may provide meaningful symptom relief.

As research into zonulin, gut barrier function, and immune responses to dietary proteins continues to develop, the once-binary conversation about gluten is evolving into something far more nuanced. Rather than a universal villain or a harmless staple, gluten may simply be a trigger for some, but not for all—highlighting the increasingly personalised nature of modern nutrition science.

Get in Touch